Nicholas Investment Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Nicholas Investment Partners’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-25,066	Closed	-$1.34M	–	359
2016 Q1	$1.34M	Sell	25,066 -41,215	-62%	-$3.04M	0.1%	267
2015 Q4	$7.49M	Buy	66,281 +10,072	+18%	+$1.11M	0.52%	46
2015 Q3	$6.62M	Buy	+56,209	New	+$7.34M	0.47%	60

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Nicholas Investment Partners's ANAC Position: Q2 2016 in Review

Nicholas Investment Partners sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 25,066 shares — an estimated $1.34M sold.

Nicholas Investment Partners first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $7.49M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Nicholas Investment Partners reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Nicholas Investment Partners sold 25,066 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.34M.
Nicholas Investment Partners first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
Nicholas Investment Partners's ANACOR PHARMACEUTICALS INC COM position peaked at $7.49M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Nicholas Investment Partners's 13F filing for Q2 2016, filed 12 Aug 2016.